Information on the Target
Evoralis is a pioneering spin-out from the University of Cambridge Hollfelder Lab, specializing in the discovery and development of plastic-depolymerizing enzymes. The company utilizes an advanced ultrahigh-throughput screening platform based on microfluidics to discover and refine enzymes capable of breaking down complex plastics into their constituent building blocks. This platform significantly accelerates enzyme screening, achieving efficiency gains of up to 1,000 times compared to traditional methods, positioning Evoralis as a leader in the quest for a sustainable circular economy for textiles and plastics.
Recently, Evoralis raised £2.5M in a Seed funding round, which will facilitate the further development of its innovative enzyme technology. The funding was led by LIFTT S.p.A, with contributions from Backbone Ventures, the Circular Plastics Accelerator, Archipelago Ventures, Parkwalk Advisors, the University of Cambridge, and various angel investors. This investment is a critical milestone that supports Evoralis’ mission to revolutionize the recycling landscape by making previously unrecyclable materials recyclable.
Industry Overview
The global textile industry is at a pivotal juncture, with fibre production nearly doubling over the past two decades to approximately 109 million tonnes in 2023. A significant portion of this production consists of materials that are currently non-recyclable, presenting a major sustainability challenge. The difficulty of recycling mixed and blended fibres is particularly pressing, with Europe alone generating around 6 million tonnes of post-consumer textile waste each year. Alarmingly, 60% of clothing sales today involve fossil-based plastics, which are inadequately addressed by existing recycling methods.
With rising environmental concerns and regulatory pressures driving demand for sustainable practices, there is a pressing need for innovative recycling solutions. The traditional textile recycling system struggles to keep pace with the rapid production and consumption cycles fueled by the fast fashion industry, culminating in significant environmental degradation. This scenario necessitates the development of alternatives that can efficiently and effectively manage textile waste.
Evoralis steps in to address these industry challenges through its groundbreaking enzymatic technology, which has the potential to recycle over 80% of textiles, including those made from mixed and blended fibres containing plastic. By enabling the separation of diverse materials within textiles, Evoralis is poised to unlock substantial economic opportunities, which could be valued at USD 560 billion.
Major fashion retailers have already recognized the potential of Evoralis' solutions, collaborating with the company to develop enzymes tailored for recycling challenging synthetic polymers like nylon and polyurethane. This growing interest highlights the critical need for innovative recycling technology within the industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The investment in Evoralis is vital for advancing the necessary technology to mitigate the challenges facing textile recycling. By developing enzymes capable of breaking down complex textiles, Evoralis directly addresses the urgent needs of the global textile industry, which is striving for sustainable solutions. The substantial financial support from LIFTT and other investors will enable Evoralis to enhance its research and development efforts, facilitating the scaling of these technologies in the market.
This investment is based on a shared vision of a future where waste is redefined as a resource. Evoralis’ innovative approach not only aligns with sustainability goals but also presents an economically viable solution that can attract further interest from investors and major fashion brands, paving the way for long-term growth and impact.
Information About the Investor
LIFTT S.p.A, the lead investor in this funding round, is a prominent firm focused on sustainable investments and innovations that promote circular economy principles. With a robust portfolio of companies aiming to address environmental challenges, LIFTT is well-positioned to support Evoralis in its mission to create efficient recycling solutions.
In addition to LIFTT, other notable investors in this round include Backbone Ventures and the Circular Plastics Accelerator, both of which are dedicated to advancing sustainable technologies. Their combined experience and commitment to fostering environmentally responsible practices add significant credibility and support to Evoralis’ transformative vision.
View of Dealert
This investment in Evoralis appears to be a promising opportunity to bridge the gap between sustainability and profitability in the textile and plastics recycling sector. The company's innovative enzyme technology and the growing demand for recycling solutions make it a valuable addition to the sustainability landscape. Given the shifting market dynamics and increasing regulatory pressures surrounding waste management, Evoralis is well-positioned to capitalize on these trends.
Furthermore, Evoralis’ established collaborations with major retailers underscores the market's readiness for innovative recycling technologies. As more brands commit to sustainable practices, the potential for rapid adoption of Evoralis’ solutions may significantly increase, enhancing the company's growth prospects.
Additionally, the strategic support from LIFTT and other investors not only provides the financial resources needed for further development but also adds strategic guidance and credibility. This collaborative environment can significantly accelerate Evoralis’ growth trajectory as it works towards providing solutions to an urgent global challenge.
In conclusion, the investment in Evoralis is likely a sound opportunity that aligns with current sustainability trends while addressing a pressing industry need. The innovative potential of its enzyme technologies positions the company as a leader in the recycling sector, making it a wise investment choice for those looking to support sustainable innovations.
Similar Deals
Cambridge Innovation Capital, SV Health Investors’ Dementia Discovery Fund, M Ventures, Pfizer Ventures → TRIMTECH Therapeutics
2025
ACF Investors → Monument Therapeutics
2025
AlbionVC and Spark Capital → Latent Technology
2025
LIFTT S.p.A
invested in
Evoralis
in 2024
in a Seed Stage deal
Disclosed details
Transaction Size: $3M